St. Jude Medical Stock – Fundamental Analysis

Price
–
–
Delisted
Reason: Not specified Delisting date: –

Not enough price data available yet.

Fundamental Data & Ratios (Balance sheet update: 2/23/2016)

Balance Sheet Total Assets 13,064,000,000.00 ROE –
Balance Sheet Total Equity 4,042,000,000.00 ROA –
Cashflow Capital Expenditures -186,000,000.00 P/FCF –
Cashflow Free Cash Flow 853,000,000.00 – –
Cashflow Operating Cash Flow 1,039,000,000.00 P/CF –
Income Earnings per Share (diluted) 3.07 Div. Yield –
Income Net Income 880,000,000.00 P/E –
Income Shares Outstanding 286,300,000.00 P/B –
Income Total Revenue 5,541,000,000.00 P/S –

Ratios calculated on: –

Company Description

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation - electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems, and Neuromodulation - neurostimulation products, which include spinal cord and deep brain stimulation devices. In August 2013, St. Jude Medical Inc announced the acquisition of Endosense SA.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.sjm.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more